Research To Practice
Innovative Oncology Education by Neil Love, MD
Latest on-demand programs
-
Expert Second Opinion
Current and Future Roles of Immunotherapy and Targeted Therapy in the Management of Advanced Gastroesophageal Cancers
-
J
-
J
-
R
- +1
-
J
-
Expert Second Opinion
Investigators Provide Perspectives on the Best-Practice Use of Immunotherapy for Endometrial Cancer
-
F
-
M
-
R
-
F
-
Oncology Today
Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer
-
W
-
W
-
Oncology Today with Dr Neil Love
Optimizing Biomarker Assessment and Related Treatment Decision-Making for Patients with HR-Positive Metastatic Breast Cancer
-
S
-
S
-
Year in Review
Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oral SERDs for Breast Cancer
-
A
-
E
-
A
-
Expert Second Opinion
Optimizing the Use of Immunotherapy, MRD Assessment and Other Novel Approaches for Patients with Localized Colorectal Cancer
-
C
-
J
-
S
-
C
Upcoming sessions
-
May292026Friday
Exciting CME Events in Chicago You Do Not Want to Miss
Cases from the Community: Investigators Discuss the Optimal Management of EGFR-Mutated Non-Small Cell Lung Cancer
In Person & Webinar Online CME -
May292026Friday
Exciting CME Events in Chicago You Do Not Want to Miss
Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Advanced Gastroesophageal Cancers
In Person & Webinar Chicago, IL CME -
May292026Friday
Exciting CME Events in Chicago You Do Not Want to Miss
Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Colorectal Cancer
In Person & Webinar Chicago, IL CME

Trusted provider of oncology medical education
Founded and led by medical oncologist Neil Love, MD, the RTP team has extensive experience developing educational programs to bridge the gap between research and patient care.
Our goals are to improve the quality of care received by patients with cancer and to assist physicians and nurses in the complex decision-making surrounding cancer treatment.

